<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

BioMedGPS Expands Coverage of Wound Care Market with Launch of US Hemostats & Sealants

Posted by Susan Paquette on 10/12/17 8:50 AM

Biosurgery.pngBioMedGPS announces expanded coverage of SmartTRAK Business Intelligence for the Surgical Wound Market with the addition of its newest module, US Hemostats & Sealants.

 Interested in the future of Biosurgery? Download our Hemostats & Sealants Article now!

SmartTRAK’s US Market for Hemostats and Sealants module covers the $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market will grow to $1.6B in 2021E, a CAGR of over 7%. The module provides real time, up-to-date market data, including 5-year market and procedural projections, quarterly revenue tracking, competitive overviews, clinical and regulatory activities and much more.

Interested in the future of Biosurgery? Download our Hemostats & Sealants Article now!

 To read the full Press Release, click here....

Topics: Biosurgery-Hemostats and Sealants

Subscribe to News and Analysis Blog Weekly Emails

SmartTRAK is the leading source of competitive intelligence used by the top ten global orthopedic and wound care companies. 

Recent Posts